Cargando…

Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1

BACKGROUND: To determine whether optimal use of serial measurements of serum levels of soluble cell adhesion molecules (CAM) can improve monitoring of disease activity in SLE. METHODS: Serum levels of soluble CAM and conventional SLE biomarkers were measured in serial samples (n = 80) from 21 SLE pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Myles J., Vyse, Simon, Shields, Adrian M., Zou, Lu, Khamashta, Munther, Gordon, Patrick A., Pitzalis, Costantino, Vyse, Timothy J., D’Cruz, David P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718032/ https://www.ncbi.nlm.nih.gov/pubmed/26746423 http://dx.doi.org/10.1186/s13075-015-0896-7

Ejemplares similares

De novo mutations implicate novel genes in systemic lupus erythematosus
por: Pullabhatla, Venu, et al.
Publicado: (2018)

Elevated levels of soluble intercellular adhesion molecule -1 in systemic lupus erythematosus
por: Kljukvina, N, et al.
Publicado: (2001)

British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus
por: Yee, Chee-Seng, et al.
Publicado: (2007)

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
por: Yee, Chee-Seng, et al.
Publicado: (2011)

Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus
por: Rivellese, Felice, et al.
Publicado: (2021)

Trans-Ancestral Fine-Mapping and Epigenetic Annotation as Tools to Delineate Functionally Relevant Risk Alleles at IKZF1 and IKZF3 in Systemic Lupus Erythematosus
por: Vyse, Timothy J., et al.
Publicado: (2020)

Autophagy is activated in systemic lupus erythematosus and required for plasmablast development
por: Clarke, Alexander J, et al.
Publicado: (2015)

UBE2L3 Polymorphism Amplifies NF-κB Activation and Promotes Plasma Cell Development, Linking Linear Ubiquitination to Multiple Autoimmune Diseases
por: Lewis, Myles J., et al.
Publicado: (2015)

Dysregulated CD46 shedding interferes with Th1‐contraction in systemic lupus erythematosus
por: Ellinghaus, Ursula, et al.
Publicado: (2017)

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine
por: Reynolds, John A, et al.
Publicado: (2022)

Editorial: Cutting edge in systemic lupus erythematosus
por: D’Cruz, David P., et al.
Publicado: (2017)

Topical calcineurin inhibitors in systemic lupus erythematosus
por: Lampropoulos, Christos E, et al.
Publicado: (2010)

Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus
por: Furie, Richard, et al.
Publicado: (2017)

Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus
por: Merrill, Joan T, et al.
Publicado: (2018)

The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus
por: Oliveira, João J., et al.
Publicado: (2018)

The genetics of lupus: a functional perspective
por: Guerra, Sandra G, et al.
Publicado: (2012)

Resequencing the susceptibility gene, ITGAM, identifies two functionally deleterious rare variants in systemic lupus erythematosus cases
por: Roberts, Amy L, et al.
Publicado: (2014)

Novel therapeutic agents in clinical development for systemic lupus erythematosus
por: Jordan, Natasha, et al.
Publicado: (2013)

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
por: Khamashta, Munther, et al.
Publicado: (2016)

Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

Intravenous Immunoglobulin in the Therapeutic Armamentarium of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2014)

Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity
por: Chen, Lingyan, et al.
Publicado: (2020)

Soluble Vascular Cell Adhesion Molecule and Cardiovascular Disease: An Epidemiological View
por: Yamagishi, Kazumasa, et al.
Publicado: (2017)

Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus
por: Cunninghame Graham, Deborah S., et al.
Publicado: (2011)

Literature review of lupus nephritis From the Arabian Gulf region
por: Al-Shujairi, Arwa, et al.
Publicado: (2022)

Vascular Disease in Systemic Lupus Erythematosus
por: Pyrpasopoulou, Athina, et al.
Publicado: (2012)

Evidence for an IFN-inducible gene, Ifi202, in the susceptibility to systemic lupus
por: Rozzo, S, et al.
Publicado: (2003)

COVID-19 and systemic lupus erythematosus genetics: A balance between autoimmune disease risk and protection against infection
por: Wang, Yuxuan, et al.
Publicado: (2022)

Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity
por: Wang, Yanyun, et al.
Publicado: (2018)

Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus
por: Sawalha, Amr H., et al.
Publicado: (2008)

Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2022)

Resilience and Treatment Adhesion in Patients with Systemic Lupus Erythematosus
por: Faria, Daniella Antunes Pousa, et al.
Publicado: (2014)

DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis
por: Wang, Susan Siyu, et al.
Publicado: (2023)

Contrast enhancement imaging in coronary arteries in patients with systemic lupus erythematosus
por: Puntmann, Valentina O, et al.
Publicado: (2012)

Adhesion molecule, soluble adhesion molecule, and cytokine levels in patients with severe burns
por: Endo, S, et al.
Publicado: (1998)

Mapping eQTLs with RNA-seq reveals novel susceptibility genes, non-coding RNAs and alternative-splicing events in systemic lupus erythematosus
por: Odhams, Christopher A., et al.
Publicado: (2017)

Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
por: Daridon, Capucine, et al.
Publicado: (2010)

Generation of restriction endonucleases barcode map to trace SARS-CoV-2 origin and evolution
por: Colombo, Federico, et al.
Publicado: (2021)

Increased concentration of serum soluble LAG3 in systemic lupus erythematosus
por: Yu, Seri, et al.
Publicado: (2012)

IL-1 family cytokines and soluble receptors in systemic lupus erythematosus
por: Italiani, Paola, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_874c8f95ifveun6k7q889fgftb